Improved survival of advanced melanoma patients receiving immunotherapy with concomitant antithrombotic therapy – A multicenter study on 2419 patients from the prospective skin cancer registry ADORegJulian Kött, N. Devereux, Glenn Geidel et al.|European Journal of Cancer|2024Cited by 16
Impact of Antithrombotic Therapy on Survival Outcomes in Advanced Melanoma Patients Receiving Targeted Therapy: Insights from the Prospective Multicenter ADOReg RegistryNick Zimmermann, Christoffer Gebhardt, Julian Kött et al.|EJC Skin Cancer|2025Cited by 0
Enhanced Overall and Progression-Free Survival in Advanced Melanoma Patients undergoing Targeted Therapy alongside Antithrombotic Treatment – Insights from a Multicenter Study involving 1,296 Patients from the Prospective Skin Cancer Registry ADORegNoah Zimmermann, Christoffer Gebhardt, Julian Kött et al.|SSRN Electronic Journal|2025Cited by 0